Reunion Neuroscience Inc.
REUN · NASDAQ
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $4,860 | $961 | $1 |
| % Growth | -100% | 405.8% | 95,989.5% | – |
| Cost of Goods Sold | $0 | $9,150 | $1,544 | $9 |
| Gross Profit | $0 | -$4,290 | -$583 | -$8 |
| % Margin | – | -88.3% | -60.7% | -840.3% |
| R&D Expenses | $12,980 | $7,311 | $3,418 | $193 |
| G&A Expenses | $12,960 | $34,483 | $12,059 | $2,628 |
| SG&A Expenses | $12,960 | $37,716 | $13,690 | $2,933 |
| Sales & Mktg Exp. | $0 | $3,233 | $1,630 | $306 |
| Other Operating Expenses | $2,023 | $3,709 | $1,338 | $140 |
| Operating Expenses | $27,963 | $48,735 | $18,445 | $3,266 |
| Operating Income | -$20,375 | -$52,600 | -$18,978 | -$3,272 |
| % Margin | – | -1,082.3% | -1,975% | -327,217.7% |
| Other Income/Exp. Net | -$17,728 | $14,497 | -$4,140 | $644 |
| Pre-Tax Income | -$38,102 | -$54,691 | -$23,118 | -$2,628 |
| Tax Expense | $28,118 | $1,096 | $303 | $23 |
| Net Income | -$66,221 | -$55,787 | -$23,421 | -$2,651 |
| % Margin | – | -1,147.9% | -2,437.4% | -265,088.6% |
| EPS | -5.69 | -4.83 | -3.54 | -0.35 |
| % Growth | -17.8% | -36.4% | -911.4% | – |
| EPS Diluted | -5.69 | -4.83 | -3.54 | -0.35 |
| Weighted Avg Shares Out | 11,639 | 11,550 | 6,614 | 7,597 |
| Weighted Avg Shares Out Dil | 11,639 | 11,550 | 6,614 | 7,597 |
| Supplemental Information | – | – | – | – |
| Interest Income | $692 | $426 | $51 | $3 |
| Interest Expense | $17,728 | $1,096 | $303 | $23 |
| Depreciation & Amortization | $3,227 | $3,603 | $1,394 | $146 |
| EBITDA | -$17,147 | -$58,731 | -$21,420 | -$6,940 |
| % Margin | – | -1,208.4% | -2,229.2% | -693,999.9% |